Susan Criswell is a Neurology physician affiliated with Barrow Neurological Institute. OpenAlex indexes 66 publications with 2,996 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
240 W Thomas Rd # 301
Phoenix, AZ 850134407
Telephone
602-406-6262Provider last certified this registry record 31 Aug 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20223 payments
- AbbVie Inc.Program year20216 payments
- Vertex Pharmaceuticals IncorporatedProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Aromatic Amino Acid Decarboxylation Inhibitor64.4%Carbidopa-Levodopa80%Carbidopa-Levodopa Er13%Rytary7%Part D<11 patientsGabapentinoids11.7%Gabapentin100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Persistent organic pollutants in prodromal Lewy Body Dementia: An exposomic investigation of neurotoxic exposures and clinical disease progression
Barrow Neurological Institute at St. Joseph'S Hospital and Medical Center
FY2026$657,088R01NS144223 - NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITY
St. Joseph'S Hospital and Medical Center
FY2023$475,542R01ES029524
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa
Movement Disorders Clinical Practice
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Marwan Sabbagh, MD
Barrow Neurological Institute
Jeremy Shefner, MD
Barrow Neurological Institute
Michael Lawton, MD
Barrow Neurological Institute
Yonas Geda, MD, MSc
Barrow Neurological Institute
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”